Logo-bi
Editorial
Abdollah Abdollahi-Aghdam, Mir Reza Majidi, Yadollah Omidi* ORCID
Bioimpacts. 2018;8(4): 237-240. doi: 10.15171/bi.2018.26
PMCID: PMC6209828     PMID: 30397578     Scopus ID: 85056101467    
Original Research
Siddharth Singh Yadav, Basant Singh Sikarwar* ORCID, Priya Ranjan, Rajiv Janardhanan
Bioimpacts. 2020;10(3): 141-150. doi: 10.34172/bi.2020.18
PMCID: PMC7416008     PMID: 32793436     Scopus ID: 85089711145    
We proposed making a case for the validation of a low-cost version of a microfluidic system capable of scanning large populations for a variety of diseases as per the WHO mandate of “One Health”.
Original Research
Abdollah Abdollahi-Aghdam ORCID, Mir Reza Majidi* ORCID, Hadi Veladi ORCID, Yadollah Omidi* ORCID
BioImpacts. 2021;11(4): 263-269. doi: 10.34172/bi.2021.35
PMCID: PMC8494256     PMID: 34631488     Scopus ID: 85113741763    
A new microfluidic-based method with integrated Au electrodes as a miniaturized detection system in anout-channel approach was developed for the simultaneous quantification of acetaminophen (AP) andphenylephrine (PHE) in pharmaceuticals and the human blood.
Editorial
Ali Pourali, Yadollah Omidi* ORCID
Bioimpacts. 2023;13(2): 85-88. doi: 10.34172/bi.2023.22023
PMCID: PMC10182445     PMID: 37193078     Scopus ID: 85152106674    
Professor Yadollah Omidi has a Ph.D. degree in Pharmaceutical Sciences (2003, Cardiff University, UK) and completed a postdoctoral program (2004) at Cardiff University. He is currently working as a full professor at Nova Southeastern University College of Pharmacy, Florida. Prof. Omidi’s research in advanced targeted diagnosis and therapy of diseases have resulted in over 300 published papers in international journals, 27 book chapters, and a few patents.
Original Article
Abdollah Abdollahi Aghdam, Mohsen Chamanara ORCID, Reza Laripour ORCID, Mohsen Ebrahimi* ORCID
Bioimpacts. 2024;14(3): 25288. doi: 10.34172/bi.2023.25288
PMCID: PMC11199932     PMID: 38938753     Scopus ID: 85194769466    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge